Psoriasis and risk of malignant lymphoma: A population-based cohort study

Abstract

In patients with psoriasis, the risk of lymphoma has been a subject of controversy and data from larger studies are limited^1-4. We therefore investigated the 5-year risk of new-onset Hodgkin lymphoma (HL), non-Hodgkin lymphoma (NHL) (excluding cutaneous T-cell lymphoma [CTCL]), and CTCL, respectively, in patients with psoriasis.

This article is protected by copyright. All rights reserved.

http://ift.tt/2k1op94